Dr. Deborah Jean Lee Wong, MD, PhD

Dr. Wong practices at UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health.

Dr. Wong's NPI, 1902044951, was assigned on January 29, 2009. Dr. Wong graduated from UC Irvine School of Medicine in 2006. Dr. Wong holds California license A101243.

Dr. Wong's primary practice is UCLA Santa Monica Medical Center, at 1250 16th Street, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 319-4000.

Dr. Wong's primary practice is UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health. Dr. Wong is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Wong to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wong practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Wong's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Wong is board certified in hematology by the American Board of Internal Medicine. Dr. Wong is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and lung cancer among the conditions Dr. Wong treats.

CMS data shows 74,349 Medicare services from Dr. Wong across 43 procedure codes in 2024, for 667 Medicare patients. Medicare paid $1,526,407 for them.

CMS counts 667 Medicare patients who saw Dr. Wong in 2024. The largest group is 65 to 74, with 284 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 15% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wong's median patient age at 67, with 57% women.

In 2024, Dr. Wong wrote 510 Medicare Part D claims for 132 patients. 61% of them were for generic drugs. CMS names the drug for 249 of them, across 14 drugs with 11 or more claims each, at $1,159,070 in total drug cost. In 2023, CMS named 209 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Wong for performance year 2024, reported as part of a group. Dr. Wong accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wong as offering telehealth.

Dmand AI links 4 papers to Dr. Wong in 2018. Dr. Wong's most frequent co-authors are Vikram K. Chand, MD, Robert Kaida Chin, MD, PhD and Subramanian Hariharan, MD.

Dmand AI links Dr. Wong to 4 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Medullary, Leukoplakia and Squamous Cell Carcinoma of Head and Neck. Open Payments lists research payments to Dr. Wong that name 6 trials.

CMS Open Payments shows 136 general payments to Dr. Wong from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 68% of the total. Bristol-Myers Squibb Company paid the most, $19,156. It also lists 34 research payments totaling $31,321 from 2019 to 2025, naming 6 clinical trials.

Dr. Wong graduated from UC Irvine School of Medicine in 2006.

Dr. Wong is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.